跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,977 条关于
“UBE3A-ATS”
全部
8,977
临床试验
3,398
药物
553
机构
209
资讯
4,817
3个月前
Oak Hill Bio to Go Public via SPAC Merger, Secures $175 Million to Advance Rugonersen for Angelman Syndrome Through Phase 3
去年
Oak Hill Bio Advances Rugonersen for Angelman Syndrome Following Promising Phase 1 Results Published in Nature Medicine
去年
Ionis' ION582 for Angelman Syndrome Advances to Phase 3 Trial
2个月前
Ionis Completes Enrollment in Pivotal Cohort of Phase 3 REVEAL Study for Obudanersen in Angelman Syndrome
去年
Ionis Announces Phase 3 Trial Design for ION582 in Angelman Syndrome
去年
ATS 2025 Conference to Showcase Groundbreaking Pulmonary Research and Patient-Centered Initiatives
去年
AstraZeneca to Present Groundbreaking Respiratory Research at ATS 2025 Conference
2个月前
Mepolizumab Demonstrates Disease Stability Benefits Across COPD Severity Spectrum at ATS 2026
去年
Ionis Pharmaceuticals' ION582 Receives FDA Fast Track Designation for Angelman Syndrome Treatment
去年
Ultragenyx's GTX-102 Shows Promise in Angelman Syndrome Phase 1/2 Trial
第 1 页,共 482 页
上一页
下一页